Transcode Therapeutics Announces FDA Clearance to Initiate Phase 1/2 Clinical Trial With Ttx-Mc138 in Patients With Advanced Solid Tumors
Transcode Therapeutics宣布批准启动针对晚期实体瘤患者的Ttx-Mc138的1/2期临床试验
Transcode Therapeutics Announces FDA Clearance to Initiate Phase 1/2 Clinical Trial With Ttx-Mc138 in Patients With Advanced Solid Tumors
Transcode Therapeutics宣布批准启动针对晚期实体瘤患者的Ttx-Mc138的1/2期临床试验
使用浏览器的分享功能,分享给你的好友吧